📢 Exciting News! EIT Health Catapult 2024-25 Semi-Finalists Announced!
We’re thrilled to unveil the 30 groundbreaking start-ups selected for the semi-finals of the 9th edition of the EIT Health Catapult!
They are: Aptadel Therapeutics, ArrayPatch Ltd, Cellectric Biosciences, Fusix Biotech GmbH, Immunofusion, Nūmi, PepKon, PoliRNA, Rejuversen, You2Yourself, Antegenes, BrightComSol, Brightmind.AI, CC Diagnostics, CheckEye, cureVision GmbH, Custom Surgical, DIGESTAID - Digestive Artificial Intelligence Development, FindAir, Galenband, Healshape, Kinetic Cortex, Lifebloom, mjn-neuro, NimBio, NIMBLE Diagnostics, PsyCurio, The Blue Box Biomedical Solutions, Tympany Medical , and VitalSigns Oy.
These innovators, spanning life sciences and healthtech, are set to showcase their life-changing solutions to top industry experts, investors, and peers from across Europe.
✨ Key Highlights:
- Semi-Final Presentations: 10 Life Sciences & 20 Healthtech start-ups will present to a public audience of healthcare professionals, investors, and experts.
- Finals Announcement in April 2025: Top 9 start-ups (3 Life Sciences & 6 Healthtech) will advance to the finals, competing for a €30,000 prize and valuable in-kind support.
- Major Prizes: Industry in-kind prizes totaling over €800,000 from top names like Amazon Web Services (AWS), eg technology Ltd, Lusíadas Saúde, AstraZeneca, and the prestigious "EIT Health Catapult Audience Alex Casta Award" 🏆
🎉 The EIT Health Catapult programme has a legacy of empowering start-ups with high-impact mentorship, rigorous business assessment, and unparalleled networking opportunities. Over eight editions, Catapult has supported 330+ companies in securing multi-million euro investments and vital support from key European partners.
👉 Stay tuned as these start-ups push boundaries, inspire change, and compete for Europe’s spotlight in healthcare innovation: https://lnkd.in/eudWYHEj
#EITHealthCatapult #HealthcareInnovation #LifeSciences #Healthtech #StartUps